The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-1-(4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)piperidine-4-carboxamide ID: ALA4553967
PubChem CID: 155555483
Max Phase: Preclinical
Molecular Formula: C24H29F2N9O4
Molecular Weight: 545.55
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)[C@H](CO)NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1
Standard InChI: InChI=1S/C24H29F2N9O4/c25-18(26)20-28-15-3-1-2-4-17(15)35(20)24-31-22(30-23(32-24)34-9-11-39-12-10-34)33-7-5-14(6-8-33)21(38)29-16(13-36)19(27)37/h1-4,14,16,18,36H,5-13H2,(H2,27,37)(H,29,38)/t16-/m0/s1
Standard InChI Key: DBJQFSGRMNBLCL-INIZCTEOSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
15.1620 -3.7929 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1609 -4.6124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8689 -5.0214 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5786 -4.6119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5758 -3.7893 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8671 -3.3840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8647 -2.5668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5692 -2.1591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5687 -1.3455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8616 -0.9352 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1533 -1.3446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1521 -2.1644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4528 -5.0205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2869 -5.0194 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7051 -4.6889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1578 -5.2958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2840 -5.8368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9882 -6.2442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6977 -5.8380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6984 -5.0198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9896 -4.6079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3653 -5.8345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5660 -6.0016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3126 -6.7759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8574 -7.3838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6589 -7.2122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9087 -6.4381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5349 -3.8897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1420 -3.3426 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.7576 -3.6374 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.4045 -6.2481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4027 -7.0653 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.1131 -5.8411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8199 -6.2512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5285 -5.8442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2353 -6.2544 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5303 -5.0270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8181 -7.0684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5249 -7.4786 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
2 13 1 0
4 14 1 0
13 15 1 0
15 16 2 0
16 23 1 0
22 13 1 0
14 17 1 0
14 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
15 28 1 0
28 29 1 0
28 30 1 0
19 31 1 0
31 32 2 0
31 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
35 37 2 0
34 38 1 6
38 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 545.55Molecular Weight (Monoisotopic): 545.2311AlogP: 0.16#Rotatable Bonds: 8Polar Surface Area: 164.62Molecular Species: NEUTRALHBA: 11HBD: 3#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.59CX Basic pKa: 5.91CX LogP: 1.28CX LogD: 1.26Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.36Np Likeness Score: -1.25
References 1. Miller MS, Mountford SJ, Pinson JA, Zheng Z, Künzli M, Patel V, Hogg SJ, Shortt J, Jennings IG, Thompson PE.. (2016) Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ., 26 (19): [PMID:27561716 ] [10.1016/j.bmcl.2016.08.028 ]